PRICE T ROWE ASSOCIATES INC /MD/ - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 81 filers reported holding IMMUNE DESIGN CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2018$122,000
-23.3%
35,252
+0.6%
0.00%
Q2 2018$159,000
+37.1%
35,045
+0.1%
0.00%
Q1 2018$116,000
-14.7%
35,010
+0.2%
0.00%
Q4 2017$136,000
-97.9%
34,948
-89.3%
0.00%
-100.0%
Q4 2015$6,575,000
-51.6%
327,432
-70.6%
0.00%
-66.7%
Q3 2015$13,576,000
-41.7%
1,112,809
-1.4%
0.00%
-40.0%
Q2 2015$23,294,000
+57.2%
1,128,041
+60.7%
0.01%
+66.7%
Q1 2015$14,820,000
-35.7%
702,041
-6.3%
0.00%
-40.0%
Q4 2014$23,059,000
+76.4%
749,141
+1.2%
0.01%
+66.7%
Q3 2014$13,073,000740,2410.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders